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Summary
Objective: Hepatocyte growth factor/scatter factor is a potent mitogen, morphogen and motogen for a variety of mainly epithelial cells.
Hepatocyte growth factor is synthesized by mesenchymal cells and can be found in various tissues. The objective of this study was to
investigate the expression and distribution patterns of this pleiotropic growth factor and its receptor, the product of the proto-oncogene c-met
in normal and osteoarthritic human knee cartilage.
Methods: Five normal and 14 osteoarthritic human cartilage samples graded histomorphologically by Mankin Score, were studied by
radioactive in-situ hybridization and immunohistochemistry for the expression of Hepatocyte growth factor and the c-met receptor.
Results: Hepatocyte growth factor could be found by immunohistochemistry in the territorial matrix surrounding the chondrocytes of calcified
cartilage and within the deep zone of normal cartilage. Chondrocytes of these cartilage zones showed also positive c-met receptor-staining.
Moreover, a small number of chondrocytes in the superficial and intermediate zone showed c-met staining. In accordance with the increased
hepatocyte growth factor staining of osteoarthritic cartilage, an enhanced expression of hepatocyte growth factor-RNA by chondrocytes of
the deep zone as well as the deeper mid zone was observed. Contrary to normal cartilage, c-met was identified immunohistochemically in
osteoarthritic chondrocytes of all cartilage zones.
Conclusion: These results indicate that hepatocyte growth factor seems to be acting in an autocrine/paracrine manner in normal and
osteoarthritic cartilage. The ubiquitous presence of the HGF/HGF-receptor complex in osteoarthritic chondrocytes suggests that hepatocyte
growth factor may contribute to the altered metabolism in osteoarthritic cartilage. © 1999 OsteoArthritis Research Society International
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Articular cartilage is composed of a highly organized and
extensive extracellular matrix (ECM), which constitutes up to
90% of the cartilage weight and a small number of embed-
ded chondrocytes.1 These chondrocytes synthesize and
organize the ECM of the articular cartilage by maintaining a
balance between synthesis and degradation of the ECM
components. In osteoarthritis (OA), which is known to be the
most common cause of pain and disability in the elderly, this
balance is disturbed, and a progressive loss of articular
cartilage, enhanced chondrocytic cell division and cluster
formation are observed.2 On the other hand, several authors
have reported on the potential of cartilage repair mecha-
nisms and described an increased synthesis of extracellular
matrix components by OA chondrocytes.3,4 Furthermore,
several cytokines and growth factors could be shown to
influence the growth, synthesis and degradation of normal
and OA articular joint cartilage.5–7 Hepatocyte growth factor
(HGF) is a heparin-binding glycoprotein which regulates
growth and differentiation of many tissues. HGF is expressed
by a variety of mesenchymal cells.8–10 The biological actions
of HGF are mediated by the c-met proto-oncogene product, a
transmembrane tyrosine kinase, which has been identified548as the HGF receptor.11 The dimeric c-met receptor has a
high affinity-binding region for the heterodimeric polypeptide
HGF, which itself is composed of a disulfide-linked 69-kDa
-subunit and a 32 kDa -subunit.12 In addition to its inter-
actions with heparin and proteoglycans HGF has been
shown to bind various collagens such as types I, III, V and
VI.13,14 Several studies showed that HGF acts in an
autocrine/paracrine manner being a key mediator of mesen-
chymal epithelial interactions.15,16 HGF is a potent mitogen
which induces growth and DNA synthesis in renal tubular
epithelial cells, keratinocytes, vascular endothelium and
hepatocytes.17–19 Furthermore, HGF acts as a morphogen
inducing renal tubular epithelium in a collagen matrix to form
a network of branching tubules.20 HGF also has motogenic
properties for human omental endothelium.21 A recent study
suggests that synovial neovascularization in rheumatoid
arthritis can be induced by HGF.22 In addition, growth of
hematopoetic stem cells is stimulated by HGF.23 HGF and
its receptor were also detected in future joint regions of
developing limb buds in mouse and rat embryos, suggesting
that HGF may have a role in the early articular morpho-
genesis.24,25 When HGF was added to chondrocytes in
vitro, their proteoglycan synthesis and cell-division rate were
significantly increased.25 However, the expression patterns
of HGF and its receptor in human normal and osteoarthritic
cartilage are largely unknown. Therefore, we used radio-
active in-situ hybridization and immunohistochemistry to
study the presence and distribution of HGF and its receptor
c-met in normal and osteoarthritic human joint cartilage.
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TISSUE PREPARATION
Fourteen osteoarthritic human cartilage samples were
obtained from 14 different patients undergoing total knee
replacement. Clinical data were carefully reviewed to
exclude any forms of secondary OA and inflammatory joint
diseases. Five normal human cartilage samples were
obtained from five patients, who underwent amputation.
The localizations of the excised samples were carefully
documented by video prints. The specimens were immedi-
ately fixed in 4% paraformaldehyde in phosphate buffered
saline (PBS), decalcified in diethyl-pyrocarbonate (DEPC)
treated 0.2 M EDTA, embedded in paraffin wax, and then
cut into 6-m thick sections. Serial sections were stained
with safranin-o and hematoxylin/eosin.HISTOLOGICAL-HISTOCHEMICAL GRADING
Routinely safranin-o stained sections of normal and
osteoarthritic cartilage were graded, according to Mankin
et al., by three different observers.26 The cartilage samples
were further classified in normal or mild, moderate and
severe osteoarthritic cartilage. Mankin score 0: normal
cartilage; Mankin score 1 to 4: mild osteoarthritic cartilage;
Mankin score 5 to 8: moderate osteoarthritic cartilage;
Mankin scores ≥9: severe osteoarthritic cartilage.Table I
Presence and distribution of HGF protein, HGF RNA and c-met protein in five normal human articular cartilage
samples obtained from five different individuals
Superficial
zone
Middle
zone
Deep
zone
Calcified
cartilage
HGF protein − − Lower DZ+ +
HGF RNA − − Lower DZ (+) or − (+) or −
c-met protein (+) (+) Lower DZ+Upper DZ (+) +
Presence and distribution of HGF protein, HGF RNA compared to c-met protein. Relative protein or RNA
expression were classified as follows: absent= −; weak=(+), moderate= +, strong= + +, very strong= + + + (not
present).Table II
Presence and distribution of HGF protein, HGF RNA and c-met protein in four mild OA cartilage samples obtained
from four different individuals
Superficial
zone
Middle
zone
Deep
zone
Calcified
cartilage
HGF protein − + + + +
HGF RNA − − + (+)
c-met protein (+) + + + +Table III
Presence and distribution of HGF protein, HGF RNA and c-met
protein in five moderate OA cartilage samples obtained from five
different individuals
Upper
cartilage
Deep
zone
Calcified
cartilage
HGF protein (+) + + +
HGF RNA (+) + (+)
c-met protein + + + + +
The remaining upper zones (superficial and middle zones) were
summarized in upper cartilage.Table IV
Presence and distribution of HGF protein, HGF RNA and c-met
protein in five severe OA cartilage samples obtained from five
different individuals
Upper
cartilage
Deep
zone
Calcified
cartilage
HGF protein + Lower DZ+ (+)
HGF RNA (+) + + (+)
c-met protein + + + + +
The remaining upper zones (superficial and middle zones) were
summarized in upper cartilage. Different results of HGF protein
and HGF RNA expression.IMMUNOHISTOCHEMISTRY
After deparaffinization, the sections were incubated with
2 mg/ml hyaluronidase (Merck, Darmstadt, Germany) in
phosphate buffered saline pH 5.5 for 15 minutes, followed
by digestion with 1 mg/ml pronase (Boehringer, Mannheim,
Germany) in PBS with pH 7.5. Non-specific binding of
the antibodies were blocked by incubation with 5% bovine
serum albumin in PBS. Each step was followed by
extensive washing in PBS. Then sections were incubated
overnight at 4°C, with a human HGF specific polyclonal
antibody, directed to a 20-mer peptide of the HGF -chain
diluted to 1:20.14 Adjacent sections were incubated, with
a human c-met specific polyclonal antibody (Santa
Cruz Biotechnology, Inc., U.S.A.), diluted 1:200, and a
human type II collagen specific monoclonal antibody (ICN,
Meckenheim, Germany), diluted 1:1000. Negative control
cartilage sections were incubated with non-immune rabbit
serum, respectively. Further, human liver sections served
as positive control. After incubation with the first antibody,
each step was followed by extensive washing in TBS.
Primary antibody were then followed by incubation with a
biotinylated anti-rabbit IgG from donkey diluted 1:200,
whereas the type II collagen sections were incubated with
a biotinylated anti-mouse IgG, diluted 1:500 (Dianova,
Hamburg, Germany). Then, a complex of streptavidin and
biotin labeled with alkaline phosphatase was added
550 D. Pfander et al.: Hepatocyte growth factor in osteoarthritisaccording to the protocol of the manufacture (Dako,
Hamburg, Germany). Finally the sections were colored with
Fast Red (SIGMA, Munich, Germany).PREPARATION AND LABELING OF PROBES
Probes specific for human HGF and c-met were
generated by oligo(dT)-primed reverse transcription of
human placenta RNA with subsequent amplification oligo-
desoxyribonucleotide primers corresponding to nucleotides
(sense: 5′-TACTCAAGCTTCCTGGAGTTCCATGATACCA
CACG-3′), (antisense: 5′-GACTCGGATCCAAGGAATGA
GTGGATTTCCCG-3′) of the HGF -chain, and (sense:
5′-GACCTAAGCTTCACAAAGCAAGCCAGATTCTGC-3′),
(antisense: 5′-GACTCGAATTCTGTTGAGTCCATGTCCC
GC-3′) of the transmembraneous -chain of the c-met
protein. The amplificons were subcloned into PcR3 (Invit-
rogen, Leek, The Netherlands) and their authenticitywas verified by restriction digests and partial sequence
analysis. Plasmids were linearized with XbaI or EcoRI
restriction endonuclease, to generate [35S]-labeled anti-
sense or sense run-off transcripts (specific activity 1.2–
1.4×109 cpm/mg) with T7 or SP6 RNA-polymerase (BRL
Gibco, Eggenstein, Germany).Fig. 1. Safranin-o staining of normal and OA cartilage sections. (A) Normal human cartilage with normal proteoglycan content (s indicates
the cartilage surfaces). (B) Mild osteoarthritic cartilage (Mankin-Score 4) with a moderate decrease in proteoglycan content (open
arrowheads) and superficial fibrillations. (C) Moderate osteoarthritic cartilage (Mankin-Score 8) with clefts, chondrocyte-clusters and an
increased loss of proteoglycans (open arrowheads). (D) Severe osteoarthritic cartilage (Mankin-Score 12) with a diffuse hypocellularity, deep
clefts (closed arrowheads) to the calcified cartilage and a great reduction in safranin-o staining (open arrowheads). Bar represents 200 m
in Figs A–D.IN-SITU HYBRIDIZATION AND AUTORADIOGRAPHY
Pre-hybridization, hybridization, washing procedures,
and RNase digestion of mis-matched sequences as well
as autoradiography were performed as described pre-
viously.27,28 In brief, tissue sections were deparaffinized in
xylene and rehydrated through graded ethanol, treated
with 0.2 M HCl, digested with pronase, fixed in 4%
paraformaldehyde/PBS, acetylated, rinsed in PBS, dehy-
drated in graded ethanols and air-dried. Sections were
hybridized at 52°C for 18 hours using 5×105 cpm of
Osteoarthritis and Cartilage Vol. 7 No. 6 551Fig. 2. Immunohistochemistry of type II collagen in normal (A) and OA cartilage sections (B, C and D), using the avidin-biotin-method. Bar
represents 200 m in Figs A–D.
Fig. 3. Immunohistochemistry of HGF in human normal and osteoarthritic cartilage, using the avidin-biotin method. (A) Normal human knee
cartilage with a weak staining of chondrocytes within and beneath the calcified cartilage (open arrowheads, s indicate the cartilage surfaces).
(B) Mild OA cartilage (Mankin-Score 4) showing an increased number of chondrocytes with positive intracellular and territorial HGF staining
in the surrounding matrix (open arrowheads). The chondrocytes beneath show a loss of their territorial HGF staining (closed arrowheads) in
close correlation to the loss of proteoglycans (compare the safranin-o staining of the adjacent section Figure 1B). (C) Moderate osteoarthritic
cartilage (Mankin-Score 8) with a further increase in the number of cells showing territorial HGF staining (open arrowheads). (D) Severe OA
cartilage (Mankin score 12) showing a reduced number of intracellular and pericellular stained chondrocytes (closed arrowheads) in the
remaining mid zone next to cartilage surface (arrow indicates a deep cleft). Note that the safranin-o stained adjacent section shows a great
reduction of proteoglycans (compare Fig. 1D). Bar represents 200 m in Figs A–D.
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modified hybridization buffer, subjected to a brief RNase A
digestion, washed briefly, dehydrated in graded ethanols,
air-dried, and dipped into Amersham’s LM1 nuclear emul-
sion (Amersham, Braunschweig, Germany). After exposure
for 30 days at 4°C, slides were developed in Kodak DI9
developer (Kodak, Hemel Hempstead, U.K.) for 3 minutes,
rinsed in 1% acetic acid and fixed in Kodak Fixer for 3
minutes. After extensive washing, the slides were finally
counterstained in Hematoxylin-Eosin and mounted in
Corbitt balsam. All sections from normal and osteoarthritic
cartilage were processed in parallel using the same
batches of probes and reagents. Hybridization of tissues
pretreated with Micrococcus nuclease verified that cellular
RNA was the target of hybridization.MICROSCOPY
Finally two slides of each immunohistochemical HGF-
and c-met stained sample as well as one of the sections
of anti-sense and sense in-situ hybridizations for HGF
and c-met were microscopically viewed, by two differentobservers. The protein and RNA expression was qualitatively
graded as follows: absent −, weak (+), moderate + and
strong + + expression of HGF- and c-met-protein as well as
HGF- and c-met-RNA (very strong + + + was not found).
These results are summarized in Tables I, II, III and IV.Fig. 4. (E–F).
Fig. 4. Immunohistochemistry for the c-met receptor in human normal and osteoarthritic cartilage, using the avidin-biotin-method (s indicates
the cartilage surfaces). (A) Normal human cartilage, showing c-met positive chondrocytes in the calcified cartilage and in the lower deep
zone. In addition several chondrocytes in the middle and superficial zone stain positive. (B) High power magnification of A showing c-met
stained chondrocytes (closed arrowheads) in the calcified cartilage and the lower deep zone above the calcified cartilage. (C) C-met staining
of chondrocytes in mild OA cartilage (Mankin Score 4), showing an increase of c-met positive cells (closed arrowheads) in the deep
zone compared to normal cartilage. (D) Magnification of C showing the pronounced c-met staining of chondrocytes (closed arrowheads)
in the deep zone. (E) Moderate OA cartilage (Mankin score 8) showing the majority of OA chondrocytes c-met positive. In particular
clustered chondrocytes next to a cleft (open arrowhead) show strong c-met expression (closed arrowheads). (F) Severe (hypocellular) OA
cartilage (Mankin score 12), showing the majority of the remaining chondrocytes positive for the HGF receptor. Bar in A represents 200 m
in Figs A, C, E and F; Bar in B represents 50 m in Figs B and D.Results
HGF and its receptor were identified by immunohisto-
chemistry in normal and osteoarthritic human knee carti-
lage. HGF RNA expression was also detectable by in-situ
hybridization, whereas c-met RNA could not be found.
In normal human cartilage (Figs 1A and 2A) HGF pro-
teins were found in the territorial matrix surrounding
chondrocytes of the lower deep zone and within calcified
cartilage (Fig. 3A). Only weak or absent HGF RNA tran-
scripts were identified in these locations by in-situ hybrid-
ization (data not shown). Parallel sections incubated with
the HGF sense probe (negative control) never showed any
signal. The HGF receptor protein was detected in normal
cartilage in a cellular or pericellular distribution. HGF recep-
tor staining was observed mainly in the chondrocytes of the
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Fig. 5. In-situ hybridization for HGF RNA in osteoarthritic cartilage. (A) Mild osteoarthritic cartilage (Mankin score 4) from human knee joints
showing HGF RNA with the antisense probe, in the deep zone chondrocytes. (B) Magnification of A showing the HGF RNA Expression.
(C) Moderate osteoarthritic cartilage (Mankin score 8) with HGF RNA expression of chondrocytes in the lower deep zone next to the
tidemark. Figure (D) and (E) showing exemplary HGF RNA expression of chondrocytes from the deep zone (E) and remaining mid zone (D)
in severe OA cartilage (Mankin-Score 10). Bar represents 50 m in Fig. A and C; Bar in B represents 12.5 m in Figure B, D and E.deep zone and within calcified cartilage (Fig. 4A and 4B).
Additionally, a small number of mid zonal and a larger
number of superficial chondrocytes showed positive c-met
receptor staining. However, one out of five samples of
normal human knee cartilage displayed labeling of c-met-
protein on chondrocytes of all zones. Immunostaining of
this specimen did not show any differences from the above
described staining pattern found in the other normal
cartilage samples.
Mild OA cartilage (Fig. 1B and 2B) showed an increased
number of chondrocytes with an enhanced and enlarged
territorial labeling of HGF protein (Fig. 3B). Contrary to the
normal control sections, HGF expression was detected in
the majority of deep zone chondrocytes (Fig. 5A and 5B). In
addition, a few single cells in the fibrillated superficial zone
were grained for HGF. In parallel, an overall increase in
the number of c-met-positive chondrocytes was observed
(Fig. 4C and 4D).
In moderate OA cartilage (Figs 1C and 2C) we found a
further increase of HGF-stained chondrocytes in the entire
deep zone and in the cells directly above the upper deep
zone (Fig. 3C). In particular, clustered chondrocytes mani-
fested an enhanced staining intensity. In accordance with
the immunohistochemical distribution, the majority of
chondrocytes in the mid zone and the deep zone displayed
HGF RNA expression as revealed (Fig. 5C). In parallel, the
average number of c-met-stained chondrocytes was further
increased compared to normal cartilage (Fig. 4E).
Severe OA cartilage (Fig. 1D and 2D) characterized by
the loss of cartilage tissue, deep clefts within the cartilage,
extensive clusters of chondrocytes and a major loss of
proteoglycans showed divergent results for immunohisto-
chemically HGF staining and in-situ hybridization of HGF
RNA. Territorial labeling for HGF protein was generally
decreased, in closed correlation to the great decrease of
safranin-o staining (Fig. 3D). Similar to moderate OA carti-
lage, we found an enhancement of HGF RNA in the deep
zone and chondrocytes of the remaining mid zone (Fig. 5Dand 5E). As seen in moderate OA cartilage, we found a
more pronounced c-met staining in most of OA chondro-
cytes in the remaining cartilage layers (Fig. 4F).
The territorial or interterritorial HGF deposition was posi-
tively correlated to the proteoglycan-content of osteo-
arthritic cartilage. HGF staining in the ECM was only found
in regions with almost normal proteoglycan content. A
greater loss of proteoglycans in OA cartilage excluded
HGF-staining of the ECM. No correlation between the
immunohistochemically staining of type II collagen and the
HGF deposition could be found.
Discussion
The results of this study demonstrate for the first time
that HGF and its receptor, the product of the c-met proto-
oncogene, are expressed by chondrocytes of adult human
articular cartilage as well as chondrocytes of OA cartilage in
vivo. The increased expression of the HGF/HGF-receptor
system in osteoarthritic cartilage, suggest a regulatory role
in the homeostasis and pathogenesis of human joint
cartilage.
C-met RNA could not be detected by in-situ hybridiz-
ation, suggesting low constitutional expression levels of the
c-met RNA in cartilage.
Our observations indicate that in normal human cartilage
only a small number of chondrocytes in the calcified and in
the deep zone synthesize HGF protein and over these
chondrocytes weak or absent HGF RNA expression was
detectable suggesting low level expression (see Table I). In
the cartilage regions of the deep zone and the calcified
cartilage we found moderate HGF receptor staining. How-
ever, a few chondrocytes in the superficial as well as in the
mid zone also showed positive c-met staining. In osteo-
arthritic cartilage, HGF RNA and protein were increased,
this was paralleled by a larger number of c-met-stained
chondrocytes (see Tables II and III). HGF seems to be
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presence of proteoglycans, whereas the absence of
proteoglycans excluded territorial HGF deposition. More-
over, in severe osteoarthritic cartilage (Mankin score ≥9)
we observed a decrease of proteoglycans and territorial
HGF protein staining in the presence of enhanced
transcript levels for HGF RNA (see Table IV).
HGF was shown to be involved in proliferation and
differentiation of many mesenchymal and epithelial tissues.
Notably, HGF and c-met expression were observed in the
somites of mouse embryos, suggesting that HGF may be
involved in the development of mesenchymal limb buds.24
In addition, Takebayashi et al. showed the expression of
HGF in those areas of limb buds in rat embryos which are
going to form joints later on.25 They also found that
chondrocytes in vitro respond to HGF with cell proliferation
and heightening their total cell number 1.8-fold. In addition,
proteoglycan synthesis was also increased 1.5-fold.
Additionally, Grumbles et al. reported that HGF and c-met
were expressed in the growth plate of rachitic rats and
in chondrocyte cultures of the proliferative zone. They
found that HGF increase type II collagen synthesis and
alkaline phosphatase activity which is a marker of cell-
differentiation.29 Interestingly, the distribution pattern of
HGF shows similarities to the described distribution of type
X collagen in OA cartilage which has been interpreted as a
molecular marker showing the premature chondrocyte dif-
ferentiation to hypertrophic cells.30 Thus it is likely that HGF
contributes to the phenotypic shift of OA chondrocytes.
Osteoarthritis is characterized by the enzymatic degra-
dation of the ECM, by various matrix metalloproteinases
and an increased synthesis of various cartilaginous matrix
components like type II collagen and aggrecan in response
to the persistent damage.4,31–33 This metabolic activation
of chondrocytes can be interpreted as a cartilage repair
mechanism. In addition, chondrocytes in OA start to prolif-
erate and form clusters. Several cytokines and growth
factors have been shown mostly in vitro to influence
the cellular mechanisms of the osteoarthritic process in
cartilage.7,34,35
Our observations support the hypothesis that HGF is
produced at significant levels in normal cartilage by the
chondrocytes of the deep zone, which also show weak to
moderate HGF-receptor staining, suggesting an autocrine/
paracrine regulatory mechanism of the HGF/HGF receptor
system. Growth factors are known to be deposited in the
ECM by binding to a variety of matrix components, such as
collagens and proteoglycans. In particular, HGF was dem-
onstrated to bind to collagens, thrombospondin, chondroitin
sulfate and hyaluronic acid.14,36 We found a close corre-
lation between HGF deposition in the ECM and the
safranin-o staining, suggesting that HGF protein binds to
the proteoglycans of articular cartilage. However, HGF
attachment to the ECM seems to be independent from type
II collagen. Thus, it can be hypothesized that in early OA
the degradation of the territorial matrix, as described by
Hollander et al.,37 is followed by an increased liberation of
HGF, which may induce the synthesis of matrix molecules
and cell division. The hypothesis that HGF is involved in
cartilage repair is supported by a study of Wakitani et al.,
who observed a complete healing of osteochondral defects
in rabbits 6 months after intra-articular injection of HGF.38
Moreover, in severe OA cartilage with a major loss of
proteoglycans we observed an increased HGF synthesis
by in-situ hybridization and the majority of chondrocytes
were also positive for the HGF receptor protein. However,
the immunohistochemical staining for the HGF protein wasonly weak or even absent. Only a few chondrocytes of the
upper OA cartilage as well as the deep zones showed a
pericellular or intracellular HGF staining. Thus, it can be
hypothesized that the decreased territorial staining of HGF
protein by immunohistochemistry is the result of the loss in
proteoglycans which normally retain HGF in cartilage.
In conclusion, we demonstrate that significant amounts
of HGF and its receptor c-met are expressed in normal and
osteoarthritic human joint cartilage in vivo. HGF is pro-
duced by chondrocytes of the calcified cartilage and deep
zone chondrocytes next to the tidemark in normal human
cartilage. The HGF receptor c-met is present in the calcified
cartilage in the deep zone and in a minor fraction of the
superficial and mid zone chondrocytes. The synthesis of
both HGF and its receptor is up-regulated in OA cartilage. It
can be hypothesized that in early OA HGF is deposited
in the ECM, but in severe OA its attachment to molecules of
the ECM particularly proteoglycans is disrupted and, thus,
the biological activity of HGF. On the other hand it can not
be excluded that the enhanced expression of HGF/HGF-
receptor complex by OA chondrocytes is the result of a
general metabolic activation with an increased synthesis in
growth factors and cytokines as described recently by
Moos et al. and other authors.7,39,40 Future work should
clarify the possible physiological functions of HGF in nor-
mal cartilage and whether HGF contributes to the cartilage
changes and the altered cartilage metabolism associated
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